{
    "2019-03-19": [
        [
            {
                "time": "2018-03-15",
                "original_text": "Why You Should Buy ABBV Stock for Income and Value",
                "features": {
                    "keywords": [
                        "ABBV",
                        "Buy",
                        "Income",
                        "Value"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-04-20",
                "original_text": "Abbott's (ABT) MitraClip COAPT Trial Shows Favorable Results",
                "features": {
                    "keywords": [
                        "Abbott",
                        "ABT",
                        "MitraClip",
                        "COAPT",
                        "Trial",
                        "Favorable",
                        "Results"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-05-10",
                "original_text": "What Makes Abbott (ABT) a New Buy Stock",
                "features": {
                    "keywords": [
                        "Abbott",
                        "ABT",
                        "New",
                        "Buy",
                        "Stock"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-06-25",
                "original_text": "3 Blue Chip Stocks That Just Hit 52-Week Highs: Are They Buys?",
                "features": {
                    "keywords": [
                        "Blue Chip",
                        "Stocks",
                        "52-Week Highs",
                        "Buys"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "general"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-07-12",
                "original_text": "Abbott Announces CE Mark for Alinityâ„¢ m Diagnostics System and Assays, the Latest in Molecular Technology, to Help Deliver Critical Test Results and Benefits to Patients",
                "features": {
                    "keywords": [
                        "Abbott",
                        "CE Mark",
                        "Alinity",
                        "Diagnostics",
                        "Molecular Technology",
                        "Test Results",
                        "Benefits",
                        "Patients"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-08-15",
                "original_text": "3 Blue-Chip Stocks That Just Hit 52-Week Highs: Are They Buys?",
                "features": {
                    "keywords": [
                        "Blue-Chip",
                        "Stocks",
                        "52-Week Highs",
                        "Buys"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "general"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}